Join
Live feed
·
INSIDERFilingvia Quantisnow
Roivant Sciences Ltd. logo

Director Fitzgerald Meghan sold $203,152 worth of shares (5,112 units at $39.74) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 36,108 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ROIV· Roivant Sciences Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ROIV (Roivant Sciences Ltd.) and more on Quantisnow.